Noxopharm - Sustainable Futures
Noxopharm is a clinical-stage drug development company founded upon the pillars of discovery and development of novel treatments in areas of unmet medical need.
At Noxopharm we aim to be on the leading edge of developing effective treatments for conditions such as cancer and sepsis that cause distressing illness and death in millions of people worldwide every year.
While Sustainability can mean different things to different companies: At Noxopharm, sustainability is all about delivering lasting value to patients by pioneering life-changing therapies through innovative science. At the same time, delivering value to shareholders through the timely delivery of a diverse drug development pipeline.
To support a sustainable future for Noxopharm, our ESG initiative – namely our focus on Environmental, Social, and Governance programs - will continue to grow in line with the growth of our company.
Click here for more information